ID

21498

Description

NCT00340080 / VIIV-CNA106030 A phase IV, randomised, multicentre, double-blind, study to evaluate the clinical utility of prospective genetic screening (HLA-B*5701) for susceptibility to abacavir hypersensitivity Assessment: Concomitant Medications Medicine: abacavir, Condition: Infection, Human Immunodeficiency Virus, Phase: 4, Clinical Study ID: CNA106030, Sponsor: ViiV

Mots-clés

  1. 25/04/2017 25/04/2017 -
Téléchargé le

25 avril 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :


Aucun commentaire

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Genetic Screening For HLA-B*5701 in Patients with HIV Concomitant Medications NCT00340080

Genetic Screening For HLA-B*5701 Concomitant Medications NCT00340080

Concomitant Medications
Description

Concomitant Medications

Alias
UMLS CUI-1
C2347852
Subject Identifier
Description

Subject Identifier

Type de données

text

Alias
UMLS CUI [1]
C2348585
Were any concomitant medications taken by the subject at screening or during the study?
Description

If Yes, record each medication on a separate line using Trade Names where possible.

Type de données

text

Alias
UMLS CUI [1]
C2347852
Drug Name
Description

If Yes, record each medication on a separate line using Trade Names where possible.

Type de données

text

Alias
UMLS CUI [1,1]
C2360065
UMLS CUI [1,2]
C2347852
Start Date
Description

Start Date

Type de données

date

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C2347852
Taken Prior to Study?
Description

Taken Prior to Study

Type de données

text

Alias
UMLS CUI [1,1]
C2826667
UMLS CUI [1,2]
C2347852
Stop Date
Description

Stop Date

Type de données

date

Alias
UMLS CUI [1,1]
C0806020
UMLS CUI [1,2]
C2347852
Ongoing Medication?
Description

Ongoing Medication

Type de données

text

Alias
UMLS CUI [1]
C2826666
Concomitant Antiretroviral Therapy
Description

Concomitant Antiretroviral Therapy

Alias
UMLS CUI-1
C1963724
UMLS CUI-2
C2347852
Subject Identifier
Description

Subject Identifier

Type de données

text

Alias
UMLS CUI [1]
C2348585
Is this subject receiving antiretroviral therapy (ART) other than the ABC-Containing product(s) during the study?
Description

If Yes, record each medication on a separate line using Trade Names where possible.

Type de données

text

Alias
UMLS CUI [1]
C1963724
Drug Name
Description

If Yes, record each medication on a separate line using Trade Names where possible.

Type de données

text

Alias
UMLS CUI [1,1]
C2360065
UMLS CUI [1,2]
C1963724
Unit Dose
Description

If Yes, record each medication on a separate line using Trade Names where possible

Type de données

text

Alias
UMLS CUI [1,1]
C0869039
UMLS CUI [1,2]
C1963724
Unit
Description

Unit

Type de données

text

Alias
UMLS CUI [1,1]
C1519795
UMLS CUI [1,2]
C1963724
Frequency
Description

Frequency

Type de données

text

Alias
UMLS CUI [1,1]
C3476109
UMLS CUI [1,2]
C1963724
Start Date
Description

Start Date

Type de données

date

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C1963724
Stop Date
Description

Stop Date

Type de données

date

Alias
UMLS CUI [1,1]
C0806020
UMLS CUI [1,2]
C1963724
Ongoing Medication?
Description

Ongoing Medication

Type de données

text

Alias
UMLS CUI [1,1]
C2826666
UMLS CUI [1,2]
C1963724

Similar models

Genetic Screening For HLA-B*5701 Concomitant Medications NCT00340080

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Concomitant Medications
C2347852 (UMLS CUI-1)
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Item
Were any concomitant medications taken by the subject at screening or during the study?
text
C2347852 (UMLS CUI [1])
Code List
Were any concomitant medications taken by the subject at screening or during the study?
CL Item
Yes (Y)
CL Item
No (N)
Drug Name
Item
Drug Name
text
C2360065 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
Start Date
Item
Start Date
date
C0808070 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
Item
Taken Prior to Study?
text
C2826667 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
Code List
Taken Prior to Study?
CL Item
Yes (Y)
CL Item
No (N)
Stop Date
Item
Stop Date
date
C0806020 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
Item
Ongoing Medication?
text
C2826666 (UMLS CUI [1])
Code List
Ongoing Medication?
CL Item
Yes (Y)
CL Item
No (N)
Item Group
Concomitant Antiretroviral Therapy
C1963724 (UMLS CUI-1)
C2347852 (UMLS CUI-2)
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Item
Is this subject receiving antiretroviral therapy (ART) other than the ABC-Containing product(s) during the study?
text
C1963724 (UMLS CUI [1])
Code List
Is this subject receiving antiretroviral therapy (ART) other than the ABC-Containing product(s) during the study?
CL Item
Yes (Y)
CL Item
No (N)
Drug Name
Item
Drug Name
text
C2360065 (UMLS CUI [1,1])
C1963724 (UMLS CUI [1,2])
Unit Dose
Item
Unit Dose
text
C0869039 (UMLS CUI [1,1])
C1963724 (UMLS CUI [1,2])
Item
Unit
text
C1519795 (UMLS CUI [1,1])
C1963724 (UMLS CUI [1,2])
Code List
Unit
CL Item
Tablet  (TAB)
CL Item
Microlitre  (MCL)
CL Item
Millilitre  (ML)
CL Item
Litre  (L)
CL Item
Microgram  (MCG)
CL Item
Milligram  (MG)
CL Item
Gram (G)
Item
Frequency
text
C3476109 (UMLS CUI [1,1])
C1963724 (UMLS CUI [1,2])
Code List
Frequency
CL Item
1 x Daily (OD)
CL Item
2 x Daily (BID)
CL Item
3 x Daily (TID)
CL Item
4 x Daily  (QID)
CL Item
As required (PRN)
Start Date
Item
Start Date
date
C0808070 (UMLS CUI [1,1])
C1963724 (UMLS CUI [1,2])
Stop Date
Item
Stop Date
date
C0806020 (UMLS CUI [1,1])
C1963724 (UMLS CUI [1,2])
Item
Ongoing Medication?
text
C2826666 (UMLS CUI [1,1])
C1963724 (UMLS CUI [1,2])
Code List
Ongoing Medication?
CL Item
Yes (Y)
CL Item
No (N)

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial